As industry shifts to continuous biomanufacturing, engineers integrate process design, digital tools, automation, and ...
SAN FRANCISCO--(BUSINESS WIRE)--Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation ...
Under the agreement, Northway Biotech will leverage its expertise in biologics manufacturing to develop and scale the production process for ATL-105 using the Pichia pastoris expression system. “With ...
Given the complexity of alternative-protein manufacturing, many biotech companies are exploring how to reduce costs with AI technologies, process improvements and novel uses for waste streams from ...
Yantai Boxin Pharmaceutical Machinery Co., Ltd., a recognized manufacturer of pharmaceutical processing and softgel production equipment, continues to strengthen its presence in the global healthcare ...
Arsenale Bioyards standardizes biomanufacturing from the industrial side, aiming to make biopharmaceutical manufacturing efficient, scalable, and cost-effective, much as the Bessemer converter did for ...
Process validation plays a critical role in the success for a new biopharmaceutical on the path of commercialization, including the crucial process characterization. As a program advances towards ...
The pharmaceutical contract manufacturing market is driven by increased outsourcing of complex processes to CMOs, enabling ...
Houston-based clinical-stage biotechnology company FibroBiologics Inc. opened a manufacturing laboratory at 9350 Kirby Drive in the Texas Technology Park. It will bring manufacturing operations ...
Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through ...
Process validation, including process characterization, is a critical step in the successful commercialization of a new biopharmaceutical on its path to commercialization. As the program approaches ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results